This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Schizophrenia
  • /
  • Comparison of the efficacy and safety of 4 and 2 m...
Journal

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.

Read time: 1 mins
Published:1st Oct 2018
Author: Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M et al.
Availability: Free full text
Ref.:Neuropsychiatr Dis Treat. 2018;14:2519-2530.
DOI:10.2147/NDT.S176676
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest